Cholangitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
m (Bot: Removing from Primary care) |
|||
| (4 intermediate revisions by one other user not shown) | |||
| Line 9: | Line 9: | ||
* There are no established measures for the primary prevention of cholangitis in otherwise healthy people. | * There are no established measures for the primary prevention of cholangitis in otherwise healthy people. | ||
* Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people. | * Treatment of [[gallstones]], [[tumors]], and infestations of parasites may reduce the risk for some people. | ||
* Patients undergoing [[ERCP]] should have prophylactic antibiotics. | * Patients undergoing [[ERCP]] should have prophylactic antibiotics.<ref name="pmid1406012">{{cite journal| author=Sauter G, Ruckdeschel G, Sauerbruch T| title=[Antibiotic prevention and therapy of infectious complications in ERCP]. | journal=Leber Magen Darm | year= 1992 | volume= 22 | issue= 5 | pages= 173-6 | pmid=1406012 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1406012 }} </ref> | ||
*Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages<ref name="urlAscending cholangitis Prevention - Epocrates Online">{{cite web |url=https://online.epocrates.com/diseases/34544/Ascending-cholangitis/Prevention |title=Ascending cholangitis Prevention - Epocrates Online |format= |work= |accessdate=}}</ref> | *Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages<ref name="urlAscending cholangitis Prevention - Epocrates Online">{{cite web |url=https://online.epocrates.com/diseases/34544/Ascending-cholangitis/Prevention |title=Ascending cholangitis Prevention - Epocrates Online |format= |work= |accessdate=}}</ref><ref name="pmid7986900">{{cite journal| author=van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ| title=Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. | journal=Clin Infect Dis | year= 1994 | volume= 19 | issue= 2 | pages= 279-86 | pmid=7986900 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7986900 }} </ref><ref name="pmid10695743">{{cite journal| author=Lillemoe KD| title=Surgical treatment of biliary tract infections. | journal=Am Surg | year= 2000 | volume= 66 | issue= 2 | pages= 138-44 | pmid=10695743 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10695743 }} </ref><ref name="pmid7716962">{{cite journal| author=Cybulski Z, Solarski J, Majewski W| title=[Infection as a risk factor in biliary system surgery]. | journal=Wiad Lek | year= 1994 | volume= 47 | issue= 15-16 | pages= 619-24 | pmid=7716962 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7716962 }} </ref> | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WikiDoc Help Menu}} | |||
{{WikiDoc Sources}} | |||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Emergency medicine]] | [[Category:Emergency medicine]] | ||
[[Category:FinalQCRequired]] | [[Category:FinalQCRequired]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Up-To-Date]] | [[Category:Up-To-Date]] | ||
[[Category:Infectious disease]] | [[Category:Infectious disease]] | ||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 20:55, 29 July 2020
|
Cholangitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cholangitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Cholangitis primary prevention |
|
Risk calculators and risk factors for Cholangitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amandeep Singh M.D.[2], Farwa Haideri [3]
Overview
There are no established measures for the primary prevention of cholangitis in otherwise healthy people, Giving antibiotics in people undergoing biliary procedures like endoscopic retrograde cholangiopancreatography (ERCP) may benefit from antibiotics.
Primary Prevention
- There are no established measures for the primary prevention of cholangitis in otherwise healthy people.
- Treatment of gallstones, tumors, and infestations of parasites may reduce the risk for some people.
- Patients undergoing ERCP should have prophylactic antibiotics.[1]
- Patients with compromised biliary systems prone to developing recurrent cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages[2][3][4][5]
References
- ↑ Sauter G, Ruckdeschel G, Sauerbruch T (1992). "[Antibiotic prevention and therapy of infectious complications in ERCP]". Leber Magen Darm. 22 (5): 173–6. PMID 1406012.
- ↑ "Ascending cholangitis Prevention - Epocrates Online".
- ↑ van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ (1994). "Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis". Clin Infect Dis. 19 (2): 279–86. PMID 7986900.
- ↑ Lillemoe KD (2000). "Surgical treatment of biliary tract infections". Am Surg. 66 (2): 138–44. PMID 10695743.
- ↑ Cybulski Z, Solarski J, Majewski W (1994). "[Infection as a risk factor in biliary system surgery]". Wiad Lek. 47 (15–16): 619–24. PMID 7716962.